<DOC>
	<DOCNO>NCT00318812</DOCNO>
	<brief_summary>The purpose study determine oral Heme Iron Polypeptide effective intravenous ( IV ) iron sucrose treatment iron-deficiency anemia patient chronic kidney disease .</brief_summary>
	<brief_title>Heme Iron Polypeptide Iron Deficiency Anemia Chronic Renal Failure</brief_title>
	<detailed_description>Iron deficiency anemia common patient pre-dialysis chronic kidney disease , associate significant morbidity . Conventional treatment oral iron salt IV iron formulation costly associate side effect . Heme iron polypeptide newly available formulation oral iron administer orally , well absorbed uremic patient , potentially few side effect . Comparison : Iron deficient anemic patient randomize either oral heme iron polypeptide IV iron sucrose six month .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Ferric oxide , saccharated</mesh_term>
	<mesh_term>Ferric Compounds</mesh_term>
	<criteria>eGFR &amp; lt ; 30 mL/min Hb 90110 g/L Age &amp; gt ; 18 Not renal replacement therapy Transferrin saturation &amp; lt ; 20 % OR Ferritin &amp; lt ; 100 mcg/L B12 &amp; folate within reference range 1 . Iron overload ( Tsat &gt; 50 % ferritin &gt; 800 Î¼g/L ) ; 2. malignancy ; recurrent gastrointestinal bleeding , major surgery infection within last 3 month ; 3. parenteral iron therapy , blood transfusion within last 3 month ; 4. pregnancy ; 5. contraindication study medication ; 6. inability refusal give consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Randomized control trial ( RCT )</keyword>
	<keyword>Prospective Studies</keyword>
	<keyword>ferric oxide , saccharated</keyword>
	<keyword>Peptides</keyword>
	<keyword>Heme</keyword>
	<keyword>Iron</keyword>
	<keyword>Erythropoietin ,</keyword>
	<keyword>Recombinant</keyword>
	<keyword>Ferritin</keyword>
	<keyword>Transferrin</keyword>
	<keyword>Treatment Outcome</keyword>
</DOC>